SPC195
Elósúlfasi alfa eða lyfjafræðilega viðunandi salt þar af
Status:
VeittApplication date:
31.5.2017Application published:
15.6.2017Grant published:
15.6.2020
Max expiry date:
29.4.2029Medicine name:
VimizimMedicine for children:
No
Timeline
Today
31.5.2017Application
15.6.2017Publication
15.6.2020Registration
29.4.2029Expires
Marketing license
IS authorization number:
EU/1/14/914/001Date:
23.5.2014
Foreign authorization number:
EU/1/14/914Date:
28.4.2014
Owner
Name:
BioMarin Pharmaceutical Inc.Address:
105 Digital Drive, Novato US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2245145